Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
11,181,416
-
Total 13F shares
-
30,097,815
-
Share change
-
-2,266,570
-
Total reported value
-
$42,738,138
-
Price per share
-
$1.42
-
Number of holders
-
56
-
Value change
-
-$4,428,963
-
Number of buys
-
26
-
Number of sells
-
24
Institutional Holders of Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) as of Q1 2024
As of 31 Mar 2024 Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) had 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,097,815 shares of stock of the company.
Largest 10 holders included Atlas Venture Life Science Advisors, LLC, BVF INC/IL, Blue Owl Capital Holdings LP, ORBIMED ADVISORS LLC, Omega Fund Management, LLC, BlackRock Inc., VANGUARD GROUP INC, Verition Fund Management LLC, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 56 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.